Consensus HealthEquity, Inc.

Equities

HQY

US42226A1079

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2025-03-17 pm EDT			5-day change	1st Jan Change
100.72 ^USD	+3.40%		+6.60%	+4.97%

Feb. 18	HealthEquity Reports 14% Increase in Health Savings Accounts From Year Ago	MT
Feb. 12	Healthequity Insider Sold Shares Worth $639,927, According to a Recent SEC Filing	MT

Evolution of the Average Target: HealthEquity, Inc.

Evolution of the Target Price: HealthEquity, Inc.

Changes in Analyst Recommendations: HealthEquity, Inc.

b2832d859d664acac6c.UlHhn8ebRsdHTIV8fNC7ADwhw5LIpGUaRCuOVz1l930.ZgnT2qHqNKJyKvM5OpOIYX8Vmt-PljcsKHL_HkxdwhxjHLH5gOF06ix41A~6047dc7ef3e0b987121b4766c8992a8b

Analysts' recommendations: HealthEquity, Inc.

Deutsche Bank Adjusts HealthEquity Price Target to $108 From $103, Maintains Buy Rating	Jan. 14	MT
Barrington Research Cuts HealthEquity Price Target to $112 From $120, Maintains Outperform Rating	Dec. 10	MT
RBC Raises Price Target on HealthEquity to $105 From $100, Keeps Outperform Rating	Dec. 10	MT
Mizuho Initiates HealthEquity at Outperform With $126 Price Target	Dec. 04	MT
Analyst recommendations: Cloudflare, Toast, Netflix, Robinhood, HSBC...	Dec. 02
RBC Raises Price Target on HealthEquity to $100 From $92, Keeps Outperform Rating	24-09-19	MT
Deutsche Bank Adjusts HealthEquity Price Target to $103 From $102, Maintains Buy Rating	24-09-05	MT
Healthequity Insider Sold Shares Worth $4,578,579, According to a Recent SEC Filing	24-06-26	MT
Wells Fargo Raises Price Target on HealthEquity to $110 From $107, Maintains Overweight Rating	24-06-20	MT
Healthequity Insider Sold Shares Worth $813,302, According to a Recent SEC Filing	24-06-10	MT
Healthequity Insider Sold Shares Worth $2,129,452, According to a Recent SEC Filing	24-06-07	MT
Deutsche Bank Adjusts HealthEquity Price Target to $102 From $95, Maintains Buy Rating	24-06-05	MT
KeyBanc Adjusts Price Target on HealthEquity to $100 From $95, Maintains Overweight Rating	24-06-05	MT
Wells Fargo Adjusts Price Target on HealthEquity to $107 From $105, Maintains Overweight Rating	24-06-04	MT
Barrington Raises Price Target on HealthEquity to $105 From $100, Maintains Outperform Rating	24-06-04	MT
JMP Securities Raises Price Target on HealthEquity to $105 From $101, Maintains Market Outperform Rating	24-06-04	MT
JMP Securities Initiates Coverage on HealthEquity With Market Outperform Rating, $101 Price Target	24-04-04	MT
JPMorgan Adjusts Price Target on HealthEquity to $108 From $86, Maintains Overweight Rating	24-04-02	MT
Jefferies Adjusts HealthEquity Price Target to $95 From $79, Maintains Buy Rating	24-03-28	MT
BTIG Research Adjusts HealthEquity Price Target to $110 From $100, Maintains Buy Rating	24-03-20	MT
RBC Raises Price Target on HealthEquity to $92 From $90, Notes Fiscal Q4 Results at High End of Preannounced Ranges; Outperform Kept	24-03-20	MT
Barrington Raises PT on HealthEquity to $100 From $85, Expects Improving Operating and Financial Performance, Keeps Outperform Rating	24-02-26	MT
Barclays Adjusts HealthEquity's Price Target to $104 From $84, Keeps Overweight Rating	24-02-23	MT
Deutsche Bank Adjusts HealthEquity Price Target to $95 From $88, Maintains Buy Rating	24-02-23	MT
RBC Raises Price Target on HealthEquity to $90 From $77, Keeps Outperform Rating	24-02-23	MT

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	HEALTHEQUITY, INC.					+19.89%
	MICROSOFT CORPORATION					+30.42%
	PALANTIR TECHNOLOGIES INC.					+0.43%
	SEA LIMITED					+22.23%
	SYNOPSYS, INC.					+40.12%
	CADENCE DESIGN SYSTEMS, INC.					+30.37%
	ATLASSIAN CORPORATION					+57.31%
	DASSAULT SYSTÈMES SE					+4.81%
	CAMBRICON TECHNOLOGIES CORPORATION LIMITED					-47.02%
	ROBLOX CORPORATION					+18.28%
	Average					+17.68%
	Weighted average by Cap.					+27.62%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

100.72USD

Average target price

116.79USD

Spread / Average Target

+15.95%

High Price Target

130.00USD

Spread / Highest target

+29.07%

Low Price Target

105.00USD

Spread / Lowest Target

+4.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Deutsche Bank Securities
Barrington Research
RBC Capital Markets
Mizuho Securities
Wells Fargo Securities
KeyBanc Capital Markets
JMP Securities
JPMorgan Chase
Jefferies & Co.
BTIG
Barclays
Baird
Raymond James
Guggenheim
Goldman Sachs
SVB Securities LLC
BofA Securities
Stephens Inc.
SVB Leerink
Cantor Fitzgerald